Tuesday, June 21 - Healthtech Leaders
(All times in EDT)
9:15am Health Tech CEO Forum
Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of a US-based Healthtech and digital health company.
Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants.
Please sign-up during registration.
11:00am Springboard’s Showcase of Women Innovators in Digital Health
Presented by Springboard Enterprises
Sponsored by Incubate Coalition
Jessica Bell van der Wal, Co-Founder & CEO, Frame Fertility
Meghan Doyle, CEO, Partum Health
Lyndsey Harper, Co-Founder & CEO, Rosy Wellness
Eleanor Jones, Founder & CEO, Skintelligent
Hillit Meidar-Alfi, CEO, Spatially Health
1:00pm Lunch
4:00pm Women’s Health CEO Forum
The LSX Women’s Health CEO Forum provides a unique, powerful and valuable space for the candid sharing of ideas and experience between 20 of the sector's entrepreneurs, CEOs, CBOs, CFOs, CCOs and Chairs of Women’s Health companies. The forum is designed to foster new ideas and create new relationships between attendees so that they can leave with tangible outcomes and that will drive their businesses and the sector forward.
Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants.
Please sign-up during registration.
5:30pm Networking Drinks Reception
The networking drink reception takes place Tuesday, June 21. Attendees can look forward to a fantastic night of networking and double down on their event relationship building.
Wednesday, June 22 - Healthtech Leaders
(All times in EDT)
9:20am Healthtech as the hot point of digital opportunities and investment for US and European entrants
The scale and diversity of Healthtech and digital health innovation has skyrocketed over the last 18 months due to the need for disruptive digital technology thoughout the pandemic and in post pandemic world. Investment has poured into the space from both experienced investors and new players in the market, and into North American companies as well as seen European start-ups seeking US capital. A panel of experts discuss:
Moderator: Rachel Ford Hutman, CEO, Ford Hutman Media
Robert Garber, Partner, 7WireVentures
Michael Greeley, General Partner, Flare Capital
Cris De Luca, Global Head, Digital Investments, Sanofi Ventures
Gaye Bok, Partner, AI and Digital Innovation Fund, Mass General Brigham
Enrico Picozza, Partner, HLM Venture Partners
10:10am Leading the way in advanced tech, big data and big partnership: how the Big Tech leaders are positioning themselves to take on healthcare
With numerous digital opportunities across healthcare space, how are leading tech and software players setting up strategic team and market plays? This panel will bring together tech leaders to discuss the key business roles of big tech in healthcare and how they are building out ecosystems and identifying the promising health applications in the next 5 years.
Moderator: Rachel Ford Hutman, CEO, Ford Hutman Media
Will Morris, Healthcare Life Sciences Lead, Google
Lorraine Marchand, General Manager, Life Sciences, Watson Health, IBM
10:45am Coffee break and refreshments
11:15am Examining large Pharma's digital transformation through innovation, collaboration and acquisitions
The combination of digital products and alongside traditional drugs to target diseases are seen as an ideal match to deliver improved patient care. However execution is not always so easy. The Pharma industry must build new strategies and business models to deliver digital health solutions to the market, and this starts with the team and integration of a digital strategy. In an industry renowned for being slow to change, this panel will discuss the critical parameters needed to bring Pharma evermore into the digital world.
Moderator: Jonathan Fox, Managing Director, Deloitte Digital
Amir Zur, Head of R&D, Digital Health, Takeda
James Williams, Global Head and Executive Director of Digital Health Research, Biogen
Gati Dharani, Director, Innovation Lab, Pfizer
Christine Roche, Digital Health Innovation Lead, Amgen
11:55am De-risking commercialization within Healthtech: Understanding how to work with payers and providers, secure US Health system partnerships to develop revenue streams, and build on DTC opportunities to reduce uncertainty
To develop a successful healthtech product line, and secure long-term investment, it is vital to articulate the company’s target market and demonstrate value to health systems. In the first instance, this can be shown through consumer/patient data and revenue from DTC sales, as it’s the easiest route to market. But in a growing space how can digital health companies stand out to the consumer and streamline clinical development capabilities? And how can companies work and build partnerships with large employers, payers, and providers? A panel of experts from across these verticals discuss how best to make these pivots and what type of partnerships they are looking for.
Moderator: Gabriel Jones, CEO & Co-Founder, Proprio
Amy Waldron, Global Leader, Healthcare & Life Sciences Solutions, Google Cloud - Health Plans, Google
Ben Linville-Engler, Chief Investment Strategist and Program Executive, MassTech
Clifford Goldsmith, US Health and Life Sciences Chief Medical Officer, Microsoft
12:35pm Accessing the EU Digital Health Market: Regulatory Issues and Challenges
The value of the global digital health industry is predicted to grow from approximately $175 billion in 2019 to approximately $660 billion by 2025. Meanwhile, the COVID-19 pandemic has only highlighted the pivotal role that digital health technologies can play in our everyday lives. With rapid growth comes increased scrutiny and regulation however, and the EU has been very active in this area over the last number of years. This session will provide an overview of some key regulatory issues and challenges affecting stakeholders involved in the development and launch of digital products in the EU.
James Gallagher, Life Sciences Regulatory Partner, Mason Hayes & Curran LLP
1:00pm Lunch
2:00pm Women's Health - a deep dive into the growth potential, investment opportunities, strategic partnerships, and deal flows
The global women’s health market is already estimated at over $40bn and continuing to grow driven partly by therapeutics but also by numerous digital, device and business model innovations. This dynamic field is set for continued investment, growth and development. In this panel experts from leading women’s health technology companies, investment funds and Pharma leaders will discuss what is next for the field, how the investment and deal-making landscape is changing and where the market opportunities are for strategic partnerships.
Moderator: Delphine O’Rourke, Partner, Goodwin Procter
Lea Von Bidder, Co-Founder and President, Ava Health
Jin Lee, Director of Digital Health, Rx+ Business Accelerator, Astellas Pharma Inc
Elizabeth Bailey, Managing Director, RH Capital
Jerrold Shapiro, President, Floelle Inc.
Rachel Braun Scherl, Business Builder, Marketing Strategist and Vagipreneur®, SPARK Solutions for Growth
2:40pm Digital Therapeutics – what does the future look like for the DTx market?
Building on the traction gained for all things digital during the pandemic, the DTx market has grown to well over $3 billion in 2021 and is expected to reach over $23 billion by 2030. As one of the most exciting areas in healthtech, it is ripe for growth and further investment. The initial surge in interest was helped by the opening of regulatory pathways but although it is clear the digital solutions are a value add to relieving the pressure in healthcare systems, there are critical hurdles that still need to be addressed to increase adoption. A panel of digital health and therapeutics experts discuss how to overcome the bottlenecks and how to continue to build and develop the sector.
Moderator: Leslie Gautam, Executive Director, Torreya
Zach Henderson, Chief Commercial Officer, Glooko
Chris Wasden, Chief Strategy Officer, Happify Health
Gati Dharani, Director, Innovation Lab, Pfizer
3:20pm The full digital transformation of hospitals - the roadmap to set up increasing digital innovation within hospitals and with the patient-centric tools.
Full digital transformation is not easy in any sector, not least with healthcare providers. Throw in a pandemic and the key service at the epicentre of it – hospitals. At the same time the pandemic highlighted the need for digital innovation across the US hospital infrastructure, to remove bottlenecks within the healthcare systems and to put the patient first. This panel will discuss:
Moderator: David Nace, Chief Medical Officer, Innovaccer
Adam Landman, VP, Chief Information and Digital Innovation Officer, Brigham & Women’s Hospital
Ivana Naeymi-Rad, Chief Operating Officer, Intelligent Medical Objects
Adam Dakin, Partner, Healthtech, Dreamit Ventures
4:00pm Can we realise the potential of AI beyond quick wins in workflow process and progress integrated AI in Pharma?
Hype and buzz around AI in healthcare - it’s been around a while, and it’s not going to dissipate. But what is still needed to realise its true value. This closing keynote panel will bring leaders in AI/ML, big data and genomics to discuss what is next, the quick wins around integrated AI drug discovery, how genomics can capitalise on increasing market size and the potential for these fields to grow together?
Moderator: Will Spagnoli, Chief Technology Officer, Phronesis Artificial Intelligence
Neil Sahota, Artificial Intelligence Advisor, United Nations
Jiye Shi, Associate VP, Head of Computational Design and Automation Platforms, Eli Lilly
Peter Henstock, Machine Learning & AI Technical Lead, Pfizer
Sean McClain, Founder & CEO, Absci
4:40pm Chair’s closing remarks
4:45pm Close of Congress
